Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer
{{output}}
Survival rates for patients with late-stage colorectal cancer (CRC) remain low due to limited efficacy of current therapeutic regimens. To overcome these challenges, novel drug targets are urgently needed. Macrophage migration inhibitory factor (MIF), an upstr... ...
